药物研发服务市场规模、份额、成长分析（按流程、按类型、按治疗领域、按药物类型、按技术、按最终用户、按地区）—产业预测 2025-2032

2023 年全球药物研发服务市场价值为 43 亿美元，预计将从 2024 年的 46.4 亿美元成长到 2032 年的 86 亿美元，预测期间（2025-2032 年）的复合年增长率为 8.0%。

由于各种未满足的医疗需求，包括神经退化性疾病、癌症、罕见遗传疾病和心血管疾病，对创新药物的需求仍然很高。随着新疾病的出现，开发新药的努力愈加活跃，药物发现服务市场预计将显着成长。这个复杂的过程需要毒理学、药物化学和药理学等领域专家的合作，因此研究机构和製药公司通常会将这些服务外包，以提高成本和时间效率。大型製药企业正在大力投资研发，以提高效率并开发专注于罕见疾病和孤儿药的新收益来源。然而，严格的法规和熟练专业人员短缺等挑战可能会影响市场的扩张。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析

药物研发服务市场规模（按流程和复合年增长率） (2025-2032)

• 市场概览
• 目标选择
• 目标检验
• 命中至线索流程
• 候选人检验
• 其他的

药物研发服务市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 药物化学
• 生物服务
• 药物代谢
• 医药服务
• 药物动力学

药物研发服务市场规模（依治疗领域及复合年增长率）（2025-2032）

• 市场概览
• 肿瘤学
• 神经病学
• 心血管疾病
• 呼吸系统疾病
• 糖尿病
• 其他的

药物研发服务市场规模（依药物类型及复合年增长率）（2025-2032）

• 市场概览
• 小分子
• 生物製药

药物研发服务市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 高通量筛检
• 生物晶片
• 药物基因学
• 奈米科技
• 光谱学

药物研发服务市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊所
• 製药公司
• 生技公司
• 研究机构

药物研发服务市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Charles River Laboratories（USA）
• WuXi AppTec（China）
• Thermo Fisher Scientific Inc.（USA）
• Evotec SE（Germany）
• Pharmaron（China）
• Labcorp（USA）
• Syngene International Limited（India）
• Eurofins Scientific（Luxembourg）
• Jubilant Biosys Limited（India）
• Curia Global, Inc.（USA）
• GenScript（USA）
• Frontage Holdings Corporation（USA）
• Piramal Enterprises Ltd.（India）
• Aragen Life Sciences Ltd.（India）
• Sygnature Discovery（UK）
• Selvita SA（Poland）
• Viva Biotech（China）
• TCG Lifesciences Pvt. Ltd.（India）
• Medicilon（China）
• Sai Life Sciences Limited（India）

结论和建议

Global Drug Discovery Services Market size was valued at USD 4.3 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 8.6 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The demand for innovative drugs remains significant, driven by various unmet medical needs across neurodegenerative diseases, cancers, rare genetic disorders, and cardiovascular issues. As new diseases emerge, the drug discovery services market is poised for considerable growth due to heightened efforts in novel drug development. This complex process necessitates collaboration among experts in fields such as toxicology, medicinal chemistry, and pharmacology, often leading research institutions and pharmaceutical companies to outsource these services for cost and time efficiencies. Major pharmaceutical firms are investing heavily in R&D to enhance efficiency and tap into fresh revenue streams focused on rare diseases and orphan drug initiatives. However, challenges such as stringent regulations and a shortage of skilled professionals may affect market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segments Analysis

Global Drug Discovery Services Market is segmented by Process, Type, Therapeutic Area, Drug Type, Technology, End User and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Candidate Validation and Others. Based on Type, the market is segmented into Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services and Pharmacokinetics. Based on Therapeutic Area, the market is segmented into Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes and Others. Based on Drug Type, the market is segmented into Small Molecules and Biologics. Based on Technology, the market is segmented into High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology and Spectroscopy. Based on End User, the market is segmented into Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies and Research Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Services Market

The global drug discovery services market is significantly driven by the rising prevalence of chronic diseases such as diabetes, dementia, and cardiovascular conditions, which collectively account for over 40 million deaths annually, representing seven out of ten fatalities worldwide. As the incidence of these chronic illnesses continues to escalate, it is anticipated that the demand for drug discovery services will expand throughout the forecast period. This surge in chronic diseases not only highlights the urgent need for effective therapeutic interventions but also presents lucrative economic opportunities for companies specializing in drug discovery, as the market increasingly seeks innovative medication solutions.

Restraints in the Global Drug Discovery Services Market

One of the key constraints affecting the Global Drug Discovery Services market is the stringent focus of regulatory agencies on ensuring the safety and efficacy of drugs before approval. Although these thorough processes are essential for maintaining confidence in medicine quality, they significantly escalate the costs associated with drug development, ultimately resulting in higher prices for the end products. This is particularly crucial in price-sensitive emerging economies, where the elevated costs can substantially hinder the adoption and accessibility of new medicines, thereby impacting overall market growth and limiting patient access to vital treatments.

Market Trends of the Global Drug Discovery Services Market

The Global Drug Discovery Services market is experiencing significant growth, driven by an escalating demand for novel therapies that address chronic diseases and improve patient outcomes. As global healthcare systems expand and evolve, pharmaceutical companies are increasingly investing in clinical trials to seek innovative solutions. This trend is further bolstered by advancements in technologies such as AI and genomics, which streamline the drug discovery process. Consequently, the market is witnessing a surge in collaboration between biopharmaceutical firms and contract research organizations (CROs), facilitating the rapid progression of drug development and increasing the overall market value.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Drug Discovery Services Market Size by Process & CAGR (2025-2032)

• Market Overview
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Candidate Validation
• Others

Global Drug Discovery Services Market Size by Type & CAGR (2025-2032)

• Market Overview
• Medicinal Chemistry
• Biology Services
• Drug Metabolism
• Pharmaceutical Services
• Pharmacokinetics

Global Drug Discovery Services Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncology
• Neurology
• Cardiovascular Disease
• Respiratory Disease
• Diabetes
• Others

Global Drug Discovery Services Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Small Molecules
• Biologics

Global Drug Discovery Services Market Size by Technology & CAGR (2025-2032)

• Market Overview
• High Throughput Screening
• Biochips
• Pharmacogenetics
• Nanotechnology
• Spectroscopy

Global Drug Discovery Services Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital & Clinics
• Pharmaceutical Companies
• Biotechnology Companies
• Research Institute

Global Drug Discovery Services Market Size & CAGR (2025-2032)

• North America (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • US
  • Canada
• Europe (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evotec SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaron (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Biosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curia Global, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Enterprises Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aragen Life Sciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sygnature Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Selvita SA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viva Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TCG Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicilon (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sai Life Sciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations